Innovative Medicines Initiative’s COMPACT

Brussels, Frankfurt, Paris, Utrecht, Ware, Szeged – November 29, 2012 – COMPACT (Collaboration on the Optimisation of Macromolecular Pharmaceutical Access to Cellular Targets), a public-private consortium funded by the Innovative Medicines Initiative (IMI), announced today the launch of a 30 million Euro project focussing on improving the delivery of biopharmaceuticals. Academic institutes, biotechnology companies, and the pharmaceutical industry have joined forces to tackle the major delivery and targeting bottlenecks in the development of novel innovative medicines based on biological macromolecules, such as proteins/peptides and oligonucleotides.